French Pharmaceuticals & Biotech Potentially Undervalued Companies

Sanofi

Market Cap: €96.7b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Oncodesign Société Anonyme

Market Cap: €99.4m

Oncodesign Société Anonyme, a biopharmaceutical company, conducts research and development work on new therapeutic and diagnostic tools with pharmaceutical firms, biotech companies, public research institutions, and investment groups.

Cellectis

Market Cap: €222.0m

A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.

Oncodesign Precision Medicine Société anonyme

Market Cap: €9.8m

A biopharmaceutical company, engages in the precision medicine business.

Vetoquinol

Market Cap: €890.6m

A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.

Virbac

Market Cap: €2.6b

Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific.

Valneva

Market Cap: €766.9m

A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.

Eurofins Scientific

Market Cap: €11.0b

Provides various analytical testing and laboratory services worldwide.

Advicenne

Market Cap: €25.7m

A specialty pharmaceutical company, develops, commercializes, and markets treatments for rare renal diseases in France and internationally.

Ipsen

Market Cap: €9.5b

Operates as a biopharmaceutical company worldwide.

Genfit

Market Cap: €154.7m

A late-stage biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases.

Euroapi

Market Cap: €288.1m

Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally.

MaaT Pharma

Market Cap: €66.0m

A late-stage clinical company, engages in the development of gut microbiome-driven therapies to modulate the immune system and improve cancer survival.

Aton

Market Cap: €6.4m

Operates as a bioscience company in France.